FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “EPIVIDIAN”, which is offered here for Conducting market research via a proprietary database in the medical research field;contract medical research services for others via a proprietary database, conducting pharmacovigilence studies, clinical outcomes assessment, clinical trial protocol feasibility assessment, and clinical trial candidate identification and selection; pharmaceutical information services, clinical data reporting on adverse event reporting systems for pharmaceutical companies; cloud computing featuring software for use by the pharmacovigilance departments of pharmaceutical companies in adverse event management and adverse event signal detection and tracking; providing cloud-based data warehousing and temporary use of non-downloadable software for clinical data reporting and business intelligence for medical records for medical practices and hospital clinics;.
Its status is currently believed to be active. Its class is unavailable. “EPIVIDIAN” is believed to be currently owned by “EPIVIDIAN, INC.”
| Owner: |
EPIVIDIAN, INC.
Owner Details |
|---|---|
| Description: |
Conducting market research via a proprietary database in the medical research field;contract medical research services for others via a proprietary database, conducting pharmacovigilence studies, clinical outcomes assessment, clinical trial protocol feasibility assessment, and clinical trial candidate identification and selection; pharmaceutical information services, clinical data reporting on adverse event reporting systems for pharmaceutical companies; cloud computing featuring software for use by the pharmacovigilance departments of pharmaceutical companies in adverse event management and adverse event signal detection and tracking; providing cloud-based data warehousing and temporary use of non-downloadable software for clinical data reporting and business intelligence for medical records for medical practices and hospital clinics;
|
| Categories: | CONDUCTING MARKET RESEARCH VIA |